Geovax ceo david dodd to participate in virtual webinar hosted by outsourced pharma

Atlanta, ga, oct. 28, 2020 (globe newswire) -- via newmediawire -- geovax labs, inc. (nasdaqcm: govx, govxw) (“geovax” or the “company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announces that ceo and chairman david dodd will participate in an upcoming virtual webinar titled, “what covid-19 vaccines teach us about all tech transfers.” sponsored by outsourced pharma (www.outsourcedpharma.com), the event will be held on wednesday, november 4, 2020 at 2:00pm et.  discussion topics include the lessons learned and best practices from the covid-19 vaccine efforts that can be applied to technology transfers.
GOVX Ratings Summary
GOVX Quant Ranking